Optimal approach to prevent CMV disease.
Posfay-Barbe
Klara M
KM
D002648:Child; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016377:Organ Transplantation / Q000379:methods*; D016896:Treatment Outcome; D019562:Viral Load
D016207:Cytokines; D007166:Immunosuppressive Agents; D015774:Ganciclovir